{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T13:52:52Z","timestamp":1772373172926,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T00:00:00Z","timestamp":1613779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10096-021-04158-w","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T16:30:06Z","timestamp":1613838606000},"page":"1773-1777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Temocillin as an alternative treatment for acute bacterial cholangitis: a retrospective microbiology susceptibility-based study of 140 episodes"],"prefix":"10.1007","volume":"40","author":[{"given":"Sylvain","family":"Chawki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Sokal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Duprilot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Leflon-Guibout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Nicolas-Chanoine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Fantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1160-2069","authenticated-orcid":false,"given":"Victoire","family":"de Lastours","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,20]]},"reference":[{"key":"4158_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jhbp.515","volume":"25","author":"M Yokoe","year":"2018","unstructured":"Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G et al (2018) Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J. Hepato-Biliary-Pancreat. Sci. 25:41\u201354. https:\/\/doi.org\/10.1002\/jhbp.515","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"4158_CR2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmi.2017.02.027","volume":"23","author":"Y Tagashira","year":"2017","unstructured":"Tagashira Y, Sakamoto N, Isogai T, Hikone M, Kosaka A, Chino R et al (2017) Impact of inadequate initial antimicrobial therapy on mortality in patients with bacteraemic cholangitis: a retrospective cohort study. Clin Microbiol Infect Off. Publ Eur Soc Clin Microbiol Infect Dis 23:740\u2013747. https:\/\/doi.org\/10.1016\/j.cmi.2017.02.027","journal-title":"Clin Microbiol Infect Off. Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"4158_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jviscsurg.2019.05.007","volume":"156","author":"A Sokal","year":"2019","unstructured":"Sokal A, Sauvanet A, Fantin B, de Lastours V (2019) Acute cholangitis: diagnosis and management. J Visc Surg 156:515\u2013525. https:\/\/doi.org\/10.1016\/j.jviscsurg.2019.05.007","journal-title":"J Visc Surg"},{"key":"4158_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/jhbp.452","volume":"24","author":"H Gomi","year":"2017","unstructured":"Gomi H, Takada T, Hwang T-L, Akazawa K, Mori R, Endo I et al (2017) Updated comprehensive epidemiology, microbiology, and outcomes among patients with acute cholangitis. J Hepato-Biliary-Pancreat Sci 24:310\u2013318. https:\/\/doi.org\/10.1002\/jhbp.452","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"key":"4158_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00534-012-0572-0","volume":"20","author":"H Gomi","year":"2013","unstructured":"Gomi H, Solomkin JS, Takada T, Strasberg SM, Pitt HA, Yoshida M et al (2013) TG13 antimicrobial therapy for acute cholangitis and cholecystitis. J. Hepato-Biliary-Pancreat. Sci. 20:60\u201370. https:\/\/doi.org\/10.1007\/s00534-012-0572-0","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"issue":"50","key":"4158_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"15","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJC, Baron EJ et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 15(50):133\u2013164. https:\/\/doi.org\/10.1086\/649554","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"4158_CR7","unstructured":"WHO. WHO. Global action plan on antimicrobial resistance [Internet]. 2015;doi: http:\/\/apps.who.int\/medicinedocs\/documents\/s21889en\/s21889en.pdf"},{"key":"4158_CR8","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Ba\u00f1o J, Guti\u00e9rrez-Guti\u00e9rrez B, Machuca I, Pascual A (2018) Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev 31. https:\/\/doi.org\/10.1128\/CMR.00079-17","DOI":"10.1128\/CMR.00079-17"},{"key":"4158_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","volume":"19","author":"A Cassini","year":"2019","unstructured":"Cassini A, H\u00f6gberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS et al (2019) Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 19:56\u201366. https:\/\/doi.org\/10.1016\/S1473-3099(18)30605-4","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 5","key":"4158_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2165\/00003495-198500295-00030","volume":"29","author":"DP Maudgal","year":"1985","unstructured":"Maudgal DP, Lanzini A, Northfield TC, Bridges C, Joseph AE (1985) Quantification of temocillin biliary excretion and gallbladder bile concentration in healthy subjects. Drugs 29(Suppl 5):146\u2013150. https:\/\/doi.org\/10.2165\/00003495-198500295-00030","journal-title":"Drugs"},{"issue":"Suppl 5","key":"4158_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2165\/00003495-198500295-00029","volume":"29","author":"GJ Poston","year":"1985","unstructured":"Poston GJ, Greengrass A, Moryson CJ (1985) Biliary concentrations of temocillin. Drugs 29(Suppl 5):140\u2013145. https:\/\/doi.org\/10.2165\/00003495-198500295-00029","journal-title":"Drugs"},{"key":"4158_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jac\/dkn511","volume":"63","author":"DM Livermore","year":"2009","unstructured":"Livermore DM, Tulkens PM (2009) Temocillin revived. J Antimicrob Chemother 63:243\u2013245. https:\/\/doi.org\/10.1093\/jac\/dkn511","journal-title":"J Antimicrob Chemother"},{"key":"4158_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s40262-017-0584-7","volume":"57","author":"K Alexandre","year":"2018","unstructured":"Alexandre K, Fantin B (2018) Pharmacokinetics and pharmacodynamics of temocillin. Clin Pharmacokinet 57:287\u2013296. https:\/\/doi.org\/10.1007\/s40262-017-0584-7","journal-title":"Clin Pharmacokinet"},{"key":"4158_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2217\/fmb-2018-0316","volume":"14","author":"I Balakrishnan","year":"2019","unstructured":"Balakrishnan I, Koumaki V, Tsakris A (2019) Temocillin: is this the right momentum for its global use? Future Microbiol 14:81\u201383. https:\/\/doi.org\/10.2217\/fmb-2018-0316","journal-title":"Future Microbiol"},{"key":"4158_CR15","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. www.eucast.org 2013;"},{"key":"4158_CR16","unstructured":"EUCAST_General_Consultation_on_temocillin_breakpoints_20191011.pdf [Internet]. [cited 2020 7];doi: http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Consultation\/2019\/EUCAST_General_Consultation_on_temocillin_breakpoints_20191011.pdf"},{"key":"4158_CR17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ijantimicag.2018.08.026","volume":"52","author":"P-L Woerther","year":"2018","unstructured":"Woerther P-L, Lepeule R, Burdet C, Decousser J-W, Rupp\u00e9 \u00c9, Barbier F (2018) Carbapenems and alternative \u03b2-lactams for the treatment of infections due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: what impact on intestinal colonisation resistance? Int. J Antimicrob Agents 52:762\u2013770. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.08.026","journal-title":"J Antimicrob Agents"},{"key":"4158_CR18","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1093\/jac\/dkw066","volume":"71","author":"K Alexandre","year":"2016","unstructured":"Alexandre K, Chau F, Gu\u00e9rin F, Massias L, Lefort A, Cattoir V et al (2016) Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli. J Antimicrob Chemother 71:1899\u20131904. https:\/\/doi.org\/10.1093\/jac\/dkw066","journal-title":"J Antimicrob Chemother"},{"key":"4158_CR19","doi-asserted-by":"publisher","unstructured":"Alexandre K, Soares A, Chau F, Fantin B, Caron F, Etienne M. Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates. J Antimicrob Chemother. 2019 1;74:1323\u20136. https:\/\/doi.org\/10.1093\/jac\/dky569","DOI":"10.1093\/jac\/dky569"},{"key":"4158_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/jac\/dku465","volume":"70","author":"P-F Laterre","year":"2015","unstructured":"Laterre P-F, Wittebole X, Van de Velde S, Muller AE, Mouton JW, Carryn S et al (2015) Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration. J Antimicrob Chemother 70:891\u2013898. https:\/\/doi.org\/10.1093\/jac\/dku465","journal-title":"J Antimicrob Chemother"},{"key":"4158_CR21","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/jac\/dkr317","volume":"66","author":"I Balakrishnan","year":"2011","unstructured":"Balakrishnan I, Awad-El-Kariem FM, Aali A, Kumari P, Mulla R, Tan B et al (2011) Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and\/or derepressed AmpC \u03b2-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 66:2628\u20132631. https:\/\/doi.org\/10.1093\/jac\/dkr317","journal-title":"J Antimicrob Chemother"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04158-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T14:44:51Z","timestamp":1626878691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04158-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,20]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4158"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04158-w","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,20]]},"assertion":[{"value":"23 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Data collection for the cohort was declared to the French \u201cCommission Nationale Informatique et des Libert\u00e9s\u201d (CNIL), registration no. 2080377 on 4\/4\/2017. Under French law, approval by an Institutional Review Board is not mandatory for retrospective monocentric studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients were informed of the study. No specific consent was necessary due to the retrospective nature of the work, according to French law.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read the paper and gave their consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Victoire de Lastours, V\u00e9ronique Leflon and Bruno Fantin report non-financial support from EUMEDICA (travel expenses). Bruno Fantin reports financial support for participating on a board organised by EUMEDICA on clinical development of temocillin. All other authors declare no conflict of interest concerning this publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}